{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:04:02Z","timestamp":1779667442847,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancers of the oesophagus, gastroesophageal junction (GEJ), and proximal stomach share epidemiological, molecular, and therapeutic characteristics. Despite their similarities, treatment guidelines vary, and the classification of GEJ tumours remains debated. While multiple meta-analyses have addressed subsets of these malignancies, a comprehensive synthesis comparing all treatment modalities across this disease spectrum is lacking. This study aims to perform a systematic review and network meta-analysis (NMA) to compare the overall survival outcomes of different treatment modalities, including surgery, chemotherapy, chemoradiotherapy, immunotherapy, and multimodal approaches, in patients with oesophageal, GEJ, and gastric cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a systematic literature search in MEDLINE (PubMed) and The Cochrane Library (CENTRAL) without date restrictions. Randomised controlled trials (RCTs) comparing eligible treatments will be included. The primary outcome will be overall survival, defined as time from diagnosis to death from any cause. Secondary outcomes will include progression-free survival, disease-specific survival, dropout rates, treatment-related adverse effects, patterns of relapse, R0 resection rates, surgical morbidity, and mortality. We will look for individual patient data (IPD) from primary studies\u2019 authors and registries. We will assess risk of bias with the Cochrane risk of bias RoB2 tool. We plan to present each pairwise comparison with risk ratios and 95% confidence intervals from random-effects meta-analysis. A random-effects NMA model will simultaneously compare all treatments in the network. We will rank interventions using P-scores. In case we manage to access IPD and we believe the transitivity assumption does not hold for a specific comparison (or we have a disconnected network), we will use population adjustment methods to estimate an indirect treatment comparison. We will apply CINeMA to assess confidence in the findings and we will report results according to PRISMA-NMA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Neoplasms of the oesophagus, the gastroesophageal junction, and the stomach are increasingly being studied together in clinical trials, a trend driven by continuous research on their molecular characteristics and shared therapeutic patterns. This NMA aims to pool evidence employing recent advances in meta-analytic models and critically assess the confidence in the results by implementing the CINeMA approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>Registered in PROSPERO (CRD42025634169).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-026-03175-0","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:35:03Z","timestamp":1776162903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of overall survival across treatment modalities for oesophageal, gastroesophageal, and gastric cancer: protocol for a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9156-8691","authenticated-orcid":false,"given":"Fani","family":"Apostolidou-Kiouti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Bettina","family":"Haidich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Mavridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini Ioanna","family":"Apostolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Tsavdaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriani","family":"Nikolakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"10","key":"3175_CR1","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol"},{"issue":"10","key":"3175_CR2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","volume":"33","author":"R Obermannov\u00e1","year":"2022","unstructured":"Obermannov\u00e1 R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, et al. Oesophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):992\u20131004.","journal-title":"Ann Oncol"},{"key":"3175_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmogo.2023.08.008","volume":"2","author":"TE Kroese","year":"2023","unstructured":"Kroese TE, Bronzwaer SFC, van Hillegersberg R, van Rossum PSN, van Laarhoven HWM. Oligometastatic disease in esophagogastric cancer: an update of recommendations on definition, diagnosis, and treatment. ESMO Gastrointestinal Oncology. 2023;2:100009.","journal-title":"ESMO Gastrointestinal Oncology"},{"key":"3175_CR4","doi-asserted-by":"crossref","unstructured":"Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. J Br Surg. 1998;85(11):1457\u20139.","DOI":"10.1046\/j.1365-2168.1998.00940.x"},{"key":"3175_CR5","doi-asserted-by":"crossref","unstructured":"Ichihara S, Uedo N, Gotoda T. Considering the esophagogastric junction as a \u2018zone.\u2019 Dig Endosc. 2017;29(S2):3\u201310.","DOI":"10.1111\/den.12792"},{"key":"3175_CR6","doi-asserted-by":"crossref","unstructured":"Nguyen NT, Thosani NC, Canto MI, Chang K, Lipham J, Abu Dayyeh B, et al. The American Foregut Society white paper on the endoscopic classification of esophagogastric junction integrity. Foregut: J Am Foregut Soc. 2022;2(4):339\u201348.","DOI":"10.1177\/26345161221126961"},{"key":"3175_CR7","doi-asserted-by":"crossref","unstructured":"Curtis NJ, Noble F, Bailey IS, Kelly JJ, Byrne JP, Underwood TJ. The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction. J Surg Oncol. 2014;109(3):202\u20137.","DOI":"10.1002\/jso.23484"},{"key":"3175_CR8","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541:169\u201375. https:\/\/doi.org\/10.1038\/nature20805.","DOI":"10.1038\/nature20805"},{"key":"3175_CR9","doi-asserted-by":"crossref","unstructured":"Vr\u00e1na D, Matzenauer M, Neoral \u010c, Aujesk\u00fd R, Vrba R, Melichar B, et al. From tumor immunology to immunotherapy in gastric and esophageal cancer. Int J Mol Sci. 2018;20(1):13.","DOI":"10.3390\/ijms20010013"},{"key":"3175_CR10","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","DOI":"10.1038\/nature13480"},{"key":"3175_CR11","doi-asserted-by":"crossref","unstructured":"Lin S, Liu T, Chen J, Li G, Dang J. Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: a network meta-analysis. PLoS ONE. 2021;16(6):e0252751.","DOI":"10.1371\/journal.pone.0252751"},{"issue":"1","key":"3175_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s40001-022-00878-7","volume":"27","author":"T Wang","year":"2022","unstructured":"Wang T, Li C, Li X, Zhai J, Wang S, Shen L. The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis. Eur J Med Res. 2022;27(1):239.","journal-title":"Eur J Med Res"},{"issue":"4","key":"3175_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/jcpt.13570","volume":"47","author":"H Gong","year":"2022","unstructured":"Gong H, Su Y, Zhao L, Ma L, Zhang L, Hou L, et al. Efficacy and safety of targeted drugs in advanced or metastatic gastric and gastroesophageal junction cancer: a network meta-analysis. J Clin Pharm Ther. 2022;47(4):493\u2013506.","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"3175_CR14","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s10120-022-01314-9","volume":"25","author":"G Grizzi","year":"2022","unstructured":"Grizzi G, Petrelli F, Di Bartolomeo M, Viti M, Texeira Moraes M, Luciani A, et al. Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis. Gastric Cancer. 2022;25(5):982\u20137.","journal-title":"Gastric Cancer"},{"issue":"3","key":"3175_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/SLA.0000000000001905","volume":"265","author":"S Pasquali","year":"2017","unstructured":"Pasquali S, Yim G, Vohra RS, Mocellin S, Nyanhongo D, Marriott P, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma. Ann Surg. 2017;265(3):481\u201391.","journal-title":"Ann Surg"},{"key":"3175_CR16","doi-asserted-by":"crossref","unstructured":"ter Veer E, Haj Mohammad N, van Valkenhoef G, Ngai LL, Mali RMA, Anderegg MC, et al. The efficacy and safety of first-line chemotherapy in advanced esophagogastric cancer: a network meta-analysis. J Natl Cancer Inst. 2016;108(10):djw166.","DOI":"10.1093\/jnci\/djw166"},{"issue":"8","key":"3175_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.25581","volume":"7","author":"U Ronellenfitsch","year":"2024","unstructured":"Ronellenfitsch U, Friedrichs J, Barbier E, Bass GA, Burmeister B, Cunningham D, et al. Preoperative chemoradiotherapy vs chemotherapy for adenocarcinoma of the esophagogastric junction. JAMA Netw Open. 2024;7(8):e2425581.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3175_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00423-023-02862-z","volume":"408","author":"P Shao","year":"2023","unstructured":"Shao P, Nima S, Tse Y, Suolang Z, Pubu C. Multimodal treatments for resectable esophagogastric junction cancer: a Bayesian network meta-analysis. Langenbecks Arch Surg. 2023;408(1):123.","journal-title":"Langenbecks Arch Surg"},{"issue":"28","key":"3175_CR19","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1200\/JCO.22.02279","volume":"41","author":"M Faron","year":"2023","unstructured":"Faron M, Cheugoua-Zanetsie M, Tierney J, Thirion P, Nankivell M, Winter K, et al. Individual participant data network meta-analysis of neoadjuvant chemotherapy or chemoradiotherapy in esophageal or gastroesophageal junction carcinoma. J Clin Oncol. 2023;41(28):4535\u201347.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3175_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"issue":"4","key":"3175_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, et al. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med. 2020;17(4):e1003082.","journal-title":"PLoS Med"},{"key":"3175_CR22","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org."},{"key":"3175_CR23","unstructured":"Higgins JP, Li T, Deeks JJ (editors). Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane. 2024. Available from https:\/\/cochrane.org\/handbook."},{"issue":"4","key":"3175_CR24","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1467-985X.2008.00593.x","volume":"172","author":"RD Riley","year":"2009","unstructured":"Riley RD. Multivariate meta-analysis: the effect of ignoring within-study correlation. J R Stat Soc Ser A Stat Soc. 2009;172(4):789\u2013811.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"3175_CR25","doi-asserted-by":"crossref","unstructured":"Schwarzer G. meta: general package for meta-analysis. 2006.","DOI":"10.32614\/CRAN.package.meta"},{"issue":"4","key":"3175_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jrsm.1058","volume":"3","author":"G R\u00fccker","year":"2012","unstructured":"R\u00fccker G. Network meta-analysis, electrical networks and graph theory. Res Synth Methods. 2012;3(4):312\u201324.","journal-title":"Res Synth Methods"},{"issue":"1","key":"3175_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G R\u00fccker","year":"2015","unstructured":"R\u00fccker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol. 2015;15(1):58.","journal-title":"BMC Med Res Methodol"},{"key":"3175_CR28","doi-asserted-by":"crossref","unstructured":"R\u00fccker G, Krahn U, K\u00f6nig J, Efthimiou O, Davies A, Papakonstantinou T, et al. netmeta: network meta-analysis using frequentist methods. 2013.","DOI":"10.32614\/CRAN.package.netmeta"},{"key":"3175_CR29","doi-asserted-by":"crossref","unstructured":"Phillippo DM. multinma: Bayesian network meta-analysis of individual and aggregate data. 2020.","DOI":"10.32614\/CRAN.package.multinma"},{"issue":"3","key":"3175_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/rssa.12579","volume":"183","author":"DM Phillippo","year":"2020","unstructured":"Phillippo DM, Dias S, Ades AE, Belger M, Brnabic A, Schacht A, et al. Multilevel network meta-regression for population-adjusted treatment comparisons. J R Stat Soc Ser A Stat Soc. 2020;183(3):1189\u2013210.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"9","key":"3175_CR31","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1093\/aje\/kwp014","volume":"169","author":"NJ Welton","year":"2009","unstructured":"Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009;169(9):1158\u201365.","journal-title":"Am J Epidemiol"},{"issue":"3","key":"3175_CR32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/bimj.201800167","volume":"62","author":"G R\u00fccker","year":"2020","unstructured":"R\u00fccker G, Petropoulou M, Schwarzer G. Network meta-analysis of multicomponent interventions. Biom J. 2020;62(3):808\u201321.","journal-title":"Biom J"},{"issue":"2","key":"3175_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/jrsm.1044","volume":"3","author":"JPT Higgins","year":"2012","unstructured":"Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012;3(2):98\u2013110.","journal-title":"Res Synth Methods"},{"issue":"7\u20138","key":"3175_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7\u20138):932\u201344.","journal-title":"Stat Med"},{"key":"3175_CR35","doi-asserted-by":"crossref","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population\u2010based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","DOI":"10.3322\/caac.21388"},{"issue":"7109","key":"3175_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"10","key":"3175_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JPT, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS ONE. 2013;8(10):e76654.","journal-title":"PLoS ONE"},{"key":"3175_CR38","first-page":"15","volume":"21","author":"M Pape","year":"2023","unstructured":"Pape M, Vissers PAJ, Dijksterhuis WPM, Bertwistle D, McDonald L, Mostert B, et al. Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study. Ther Adv Med Oncol. 2023;21:15.","journal-title":"Ther Adv Med Oncol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03175-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:52Z","timestamp":1779667252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03175-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3175"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03175-0","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}